Atracurium [atrakurium]
- Terms
-
atracurii besilas
atrakurium besylát
Tracrium
-
33 A 74
Atracurium Besilate
Atracurium Besylate
Atracurium Dibesylate
BW-33A
Relatrac
Tracrium
A non-depolarizing neuromuscular blocking agent with short duration of action. Its lack of significant cardiovascular effects and its lack of dependence on good kidney function for elimination provide clinical advantage over alternate non-depolarizing neuromuscular blocking agents.
- DUI
- D001279 MeSH Browser
- CUI
- M0001922
- CAS
- Isoquinolinium, 2,2'-(1,5-pentanediylbis(oxy(3-oxo-3,1-propanediyl)))bis(1-((3,4-dimethoxyphenyl)methyl))-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-
- Previous indexing
- Isoquinolines (1966-1986)
- History note
- 87
- Public note
- 87
Allowable subheadings
- AD
- administration & dosage 13
- AE
- adverse effects 3
- AG
- agonists
- AA
- analogs & derivatives 14
- AN
- analysis
- AI
- antagonists & inhibitors 1
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology 1
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics 3
- PD
- pharmacology 5
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 11
- TO
- toxicity
- UR
- urine